
Aron Jaffe
@jaffeab
Followers
717
Following
762
Media
205
Statuses
2K
SVP @ https://t.co/5bCQBx9DVy;Former SVP Head of Research @chromamedicine;EIR @ThirdRockV;Reg Med, uBiome group leader/Resp DA co-lead @NovartisScience. Opinions mine
Boston, MA
Joined October 2011
Our work describing the development of a potent epigenetic editor targeting human #PCSK9 for durable reduction of LDL-C is out in @NatureMedicine today!.Cc: @chromamedicine @nchromabio.1/9.
1
1
5
Happy Father’s Day to @rcjaffe & all the Dads out there!. I dont @ him often, but 👇🏼 is one of my favorites.
My father @rcjaffe officially retired this week. His last day @UICPhysiology was Monday, 8/31. Although my Dad always described himself as ‘small potatoes’, and since there was no departmental send-off, I wanted to highlight a few things about his career (thread).
0
0
2
RT @Carolynyjohnson: In case you needed a smile this Tuesday: 10-month-old baby KJ, who received a bespoke gene-editing therapy after a six….
0
67
0
When a therapeutic approach works, it's on us as a global community to figure out how to get it to ALL patients in need. Great piece by @Jasonmmast . What Baby KJ means for the CRISPR gene editing industry via @statnews.
0
0
4
Absolutely amazing. Congratulations to @kiranmusunuru @UrnovFyodor & everyone involved.
Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism".—the 1st human to undergo custom genome editing.—outgrowth of decades of NIH funded research.@NEJM
0
0
1
“The most effective way to prevent the spread of measles is the MMR vaccine”.
I came to Gaines County, Texas, today to comfort the Hildebrand family after the loss of their 8-year-old daughter Daisy. I got to know the family of 6-year-old Kayley Fehr after she passed away in February. I also developed bonds with and deep affection for other members of.
0
0
0
Congratulations @davidrliu!.
David Liu receives Breakthrough Prize in Life Sciences. @davidrliu is honored for the development of base editing and prime editing, two gene editing technologies transforming medicine. @brkthroughprize
0
0
5
RT @doctorveera: I and my colleague, Sahar Gelfman, at RGC had the privilege to write a News and Views article for @nature about a recent w….
0
41
0
This is a big day for patients with AATD and a big win for genomic medicine. Congrats to the entire Beam Team @BeamTx!.
Today, Beam announced positive initial data for BEAM-302 from its Phase 1/2 trial in alpha-1 antitrypsin deficiency (AATD), establishing clinical proof-of-concept and demonstrating the first ever clinical gene editing correction of a disease-causing mutation.
0
0
2
Congratulations to @bigosi @SethEttenberg & the entire @BlueRockTx team! . BlueRock Therapeutics receives FDA Fast Track Designation for OpCT-001 for the treatment of primary photoreceptor diseases
0
0
1